Marinus Pharmaceuticals, Inc.

Q2 2022 13F Holders

Symbol
MRNS
CUSIP
56854Q200
Type
Equity
Class
COM NEW
Num filings
79
Total reported value, excl. options
$141 M
Manager Report Date Value ($000) Shares Option Type